Science Daily -
21 Mar 2014 22:48
Two studies are providing new insight into germline epidermal growth factor receptor T790M mutation in familial non-small cell lung cancer. The findings suggest the need for tailored approaches for early detection and treatment, as well as for genetic testing to identify carriers. "These studies now solidify the fact that routine clinical management of lung cancer now has to include the awareness of this inherited cancer syndrome," said one expert.
Share this Article
Comment on this Article
Please to comment